Display options
Share it on

Evid Based Complement Alternat Med. 2014;2014:605452. doi: 10.1155/2014/605452. Epub 2014 Dec 28.

Antihypertensive Effect of Syzygium cumini in Spontaneously Hypertensive Rats.

Evidence-based complementary and alternative medicine : eCAM

Rachel Melo Ribeiro, Vicente Férrer Pinheiro Neto, Kllysmann Santos Ribeiro, Denilson Amorim Vieira, Iracelle Carvalho Abreu, Selma do Nascimento Silva, Maria do Socorro de Sousa Cartágenes, Sônia Maria de Farias Freire, Antonio Carlos Romão Borges, Marilene Oliveira da Rocha Borges

Affiliations

  1. Laboratory of Pharmacology, Department of Physiological Science, Federal University of Maranhão (UFMA), Avenida dos Portugueses 1966, Bacanga, 65080-805 São Luís, MA, Brazil.
  2. Department of Veterinary Medicine, State University of Maranhão (UEMA), 65055-970 São Luís, MA, Brazil.

PMID: 25614751 PMCID: PMC4295347 DOI: 10.1155/2014/605452

Abstract

This study evaluated the in vivo potential antihypertensive effect of hydroalcoholic extract of Syzygium cumini leaves (HESC) in normotensive Wistar rats and in spontaneously hypertensive rats (SHR), as well as its in vitro effect on the vascular reactivity of resistance arteries. The hypotensive effect caused by intravenous infusion of HESC (0.01-4.0 mg/kg) in anesthetized Wistar rats was dose-dependent and was partially inhibited by pretreatment with atropine sulfate. SHR received HESC (0.5 g/kg/day), orally, for 8 weeks and mean arterial pressure, heart rate, and vascular reactivity were evaluated. Daily oral administration of HESC resulted in a time-dependent blood pressure reduction in SHR, with a maximum reduction of 62%. In the endothelium-deprived superior mesenteric arteries rings the treatment with HESC reduced by 40% the maximum effect (E max⁡) of contraction induced by NE. The contractile response to calcium and NE of endothelium-deprived mesenteric rings isolated from untreated SHR was reduced in a concentration-dependent manner by HESC (0.1, 0.25, and 0.5 mg/mL). This study demonstrated that Syzygium cumini reduces the blood pressure and heart rate of SHR and that this antihypertensive effect is probably due to the inhibition of arterial tone and extracellular calcium influx.

References

  1. Environ Sci Pollut Res Int. 2014;21(13):7956-72 - PubMed
  2. Pharmacol Rep. 2005;57 Suppl:97-107 - PubMed
  3. J Physiol. 1984 Dec;357:327-39 - PubMed
  4. J Ethnopharmacol. 2009 Jul 30;124(3):457-62 - PubMed
  5. Evid Based Complement Alternat Med. 2011;2011:789871 - PubMed
  6. Br J Pharmacol. 1999 Jun;127(3):772-8 - PubMed
  7. Can Fam Physician. 2008 Nov;54(11):1529-33 - PubMed
  8. In Vivo. 1991 Mar-Apr;5(2):143-7 - PubMed
  9. J Pharm Pharmacol. 1994 Apr;46(4):242-51 - PubMed
  10. Acta Pol Pharm. 2007 Nov-Dec;64(6):547-52 - PubMed
  11. Biol Pharm Bull. 2007 Jul;30(7):1278-83 - PubMed
  12. Am J Physiol. 1990 Jul;259(1 Pt 1):C3-18 - PubMed
  13. J Med Food. 2004 Summer;7(2):187-91 - PubMed
  14. J Complement Integr Med. 2014 Feb 20;11(1):1-7 - PubMed
  15. J Ethnopharmacol. 2001 Jul;76(2):139-43 - PubMed
  16. Evid Based Complement Alternat Med. 2011;2011:810207 - PubMed
  17. Fitoterapia. 2003 Dec;74(7-8):650-7 - PubMed
  18. Biol Pharm Bull. 2008 Nov;31(11):2090-6 - PubMed
  19. Br J Pharmacol. 1998 Mar;123(5):847-54 - PubMed
  20. Pharmacol Ther. 1996;72(3):215-41 - PubMed
  21. Cell Mol Life Sci. 2010 Feb;67(3):405-17 - PubMed
  22. Evid Based Complement Alternat Med. 2011;2011:127641 - PubMed
  23. Circulation. 2013 Jan 1;127(1):e6-e245 - PubMed
  24. Rev Fac Odontol Ribeiro Preto. 1986 Jul-Dec;23(2):213-5 - PubMed
  25. J Med Food. 2014 Feb;17(2):244-53 - PubMed
  26. Hypertension. 2003 Dec;42(6):1206-52 - PubMed
  27. Clin Exp Hypertens A. 1985;7(11):1583-96 - PubMed
  28. Braz J Med Biol Res. 2005 Mar;38(3):463-8 - PubMed
  29. J Med Food. 2011 Apr;14(4):353-9 - PubMed
  30. JAMA. 2002 Oct 16;288(15):1882-8 - PubMed
  31. Hypertension. 1999 Oct;34(4 Pt 2):897-901 - PubMed
  32. J Gen Physiol. 2010 Sep;136(3):283-91 - PubMed
  33. Life Sci. 1999;64(5):279-303 - PubMed
  34. J Ethnopharmacol. 2002 Jun;81(1):81-100 - PubMed
  35. Pharmacol Rev. 1997 Jun;49(2):157-230 - PubMed
  36. J Ethnopharmacol. 2007 Jan 3;109(1):60-71 - PubMed
  37. Life Sci. 1988;42(2):111-22 - PubMed
  38. J Ethnopharmacol. 2006 Mar 8;104(1-2):129-31 - PubMed
  39. Molecules. 2008;13(10):2545-56 - PubMed
  40. Evid Based Complement Alternat Med. 2011;2011: - PubMed
  41. Cardiovasc Toxicol. 2013 Sep;13(3):278-89 - PubMed
  42. J Ethnopharmacol. 2005 Jan 4;96(1-2):43-8 - PubMed

Publication Types